LEUKEMIA-ASSOCIATED TRANSPLANTATION ANTIGENS RELATED TO MURINE LEUKEMIA VIRUS : THE X.1 SYSTEM: IMMUNE RESPONSE CONTROLLED BY A LOCUS LINKED TOH-2

por Sato, H., Boyse, E. A., Aoki, T., Iritani, C., Old, L. J.
Publicado 1973

MOUSE ISOANTIGENS: SEPARATION OF SOLUBLE TL (THYMUS-LEUKEMIA) ANTIGEN FROM SOLUBLE H-2 HISTOCOMPATIBILITY ANTIGEN BY COLUMN CHROMATOGRAPHY

por Davies, D. A. L., Boyse, E. A., Old, L. J., Stockert, Elisabeth
Publicado 1967

Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase

por Kelly, M P, Jungbluth, A A, Wu, B-W, Bomalaski, J, Old, L J, Ritter, G
Publicado 2012

RELATION OF CHROMOSOME 4 (LINKAGE GROUP VIII) TO MURINE LEUKEMIA VIRUS-ASSOCIATED ANTIGENS OF AKR MICE

por Ikeda, H., Stockert, E., Rowe, W. P., Boyse, E. A., Lilly, F., Sato, H., Jacobs, S., Old, L. J.
Publicado 1973

Short communication: A33scFv–cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy

por Deckert, P M, Renner, C, Cohen, L S, Jungbluth, A, Ritter, G, Bertino, J R, Old, L J, Welt, S
Publicado 2003

Multimarker RT–PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients

por Nissan, A, Jager, D, Roystacher, M, Prus, D, Peretz, T, Eisenberg, I, Freund, H R, Scanlan, M, Ritter, G, Old, L J, Mitrani-Rosenbaum, S
Publicado 2006

Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours

por Jungbluth, A A, Stockert, E, Chen, Y-T, Kolb, D, Iversen, K, Coplan, K, Williamson, B, Altorki, N, Busam, K J, Old, L J
Publicado 2000

Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM).

por Antoniw, P., Farnsworth, A. P., Turner, A., Haines, A. M., Mountain, A., Mackintosh, J., Shochat, D., Humm, J., Welt, S., Old, L. J., Yarranton, G. T., King, D. J.
Publicado 1996

Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR

por Panousis, C, Rayzman, V M, Johns, T G, Renner, C, Liu, Z, Cartwright, G, Lee, F-T, Wang, D, Gan, H, Cao, D, Kypridis, A, Smyth, F E, Brechbiel, M W, Burgess, A W, Old, L J, Scott, A M
Publicado 2005

Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond

por Britten, C. M., Janetzki, S., van der Burg, S. H., Huber, C., Kalos, M., Levitsky, H. I., Maecker, H. T., Melief, C. J. M., O’Donnell-Tormey, J., Odunsi, K., Old, L. J., Pawelec, G., Roep, B. O., Romero, P., Hoos, A., Davis, M. M.
Publicado 2010